Article Information
History
- November 9, 2023.
Article Versions
- Version 1 (March 10, 2023 - 11:54).
- Version 2 (July 17, 2023 - 14:54).
- Version 3 (August 1, 2023 - 13:49).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Caroline J. Bull1,2,3,*,
- Emma Hazelwood1,2,*,
- Joshua A. Bell1,2,
- Vanessa Y. Tan1,2,
- Andrei-Emil Constantinescu1,2,
- Maria Carolina Borges1,2,
- Danny N. Legge3,
- Kimberly Burrows1,2,
- Jeroen R. Huyghe4,
- Hermann Brenner5,6,7,
- Sergi Castellví-Bel8,
- Andrew T Chan9,10,11,12,13,14,
- Sun-Seog Kweon15,16,
- Loic Le Marchand17,
- Li Li18,
- Iona Cheng19,20,
- Rish K. Pai21,
- Jane C. Figueiredo22,
- Neil Murphy23,
- Marc J. Gunter23,24,
- Nicholas J. Timpson1,2 and
- Emma E. Vincent1,2,3,#
- 1MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
- 2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
- 3Translational Health Sciences, Bristol Medical School, University of Bristol, UK
- 4Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
- 5Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 6Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
- 7German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
- 8Gastroenterology Department, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain
- 9Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
- 10Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
- 11Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
- 12Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
- 13Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA
- 14Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA
- 15Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Korea
- 16Jeonnam Regional Cancer Center, Chonnam National University Hwasun Hospital, Hwasun, Korea
- 17University of Hawaii Cancer Center, Honolulu, Hawaii, USA
- 18Department of Family Medicine, University of Virginia, Charlottesville, Virginia, USA
- 19Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA
- 20University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, San Francisco, California, USA
- 21Department of Pathology and Laboratory Medicine, Mayo Clinic, Arizona, Scottsdale, Arizona, USA
- 22Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
- 23Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France
- 24Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom
- ↵#Corresponding author:
Emma E. Vincent, emma.vincent{at}bristol.ac.uk
↵* These authors contributed equally and are joint first authors.
Posted November 09, 2023.
Identifying metabolic features of colorectal cancer liability using Mendelian randomization
